MPH Health Care

Earnings Release • Aug 29, 2014

News Details

Corporate | 29 August 2014 08:00

MPH Mittelständische Pharma Holding AG: 1st half-year 2014: sales of EUR 117.6 million (+4.6 % sales growth; net profit of EUR 4.5 million (+7.5 % profit growth)

MPH Mittelständische Pharma Holding AG / Key word(s): Interim Report/Half Year Results

29.08.2014 / 08:00

---

1st half-year 2014: sales of EUR 117.6 million (+4.6 % sales growth; net profit of EUR 4.5 million (+7.5 % profit growth)

In the first half of 2014 MPH Group achieved sales of EUR 117.6 million (prior-year period: EUR 112.4 million) and thus an increase of 4.6 % compared to the same period of the previous year. Net income amounted to EUR 4.5 million (prior-year period: EUR 4.2 million), which corresponds to a growth of 7.5 % in comparison with the prior-year period.

For detailed information please refer to our half-year report 2014 .

About MPH Mittelständische Pharma Holding AG:

The company MPH Mittelständische Pharma Holding AG, based in Berlin, has strategically concentrated its activities on the growth segments of the healthcare market and is aimed to make a contribution towards cutting costs in the healthcare system.

The focus lies on medicines manufactured on the basis of patent-free and patent-protected active substances for the therapy of chronic diseases. Complementary, services for individual patient therapies, aesthetic surgeries and other medical treatments are offered along the value-added-chain in the healthcare market.

MPH Mittelständische Pharma Holding AG is listed in the Entry Standard (Open Market) of the Frankfurt stock exchange.

Key figures for the share of MPH Mittelständische Pharma Holding AG:

Subscribed capital: EUR 42,813,842.00.

Contact: Frau Linda Reichelt

MPH Mittelständische Pharma Holding AG

Fasanenstraße 77

D-10623 Berlin

Phone:+49 (0)30 897308660 Fax:+49 (0)30 897308669

E-Mail: ir@mph-ag.de Web: www.mph-ag.de

---

29.08.2014 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language:	English
Company:	MPH Mittelständische Pharma Holding AG
	Fasanenstraße 77
	10623 Berlin
	Germany
Phone:	030 / 897 308 660
Fax:	030 / 897 308 669
E-mail:	info@mph-ag.de
Internet:	www.mph-ag.de
ISIN:	DE000A0NF697
WKN:	A0NF69
Listed:	Freiverkehr in Berlin, Düsseldorf, Stuttgart; Frankfurt in Open Market (Entry Standard)

End of News	DGAP News-Service

- - -
284480  29.08.2014